BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2467815)

  • 1. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
    Defrance T; Vanbervliet B; Durand I; Banchereau J
    Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and regulation of CD5 on in vitro activated human B cells.
    Freedman AS; Freeman G; Whitman J; Segil J; Daley J; Levine H; Nadler LM
    Eur J Immunol; 1989 May; 19(5):849-55. PubMed ID: 2472277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
    Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
    J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.
    Pène J; Rousset F; Brière F; Chrétien I; Paliard X; Banchereau J; Spits H; De Vries JE
    J Immunol; 1988 Aug; 141(4):1218-24. PubMed ID: 3135324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
    Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
    Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD5 and CD38 by human CD5- B cells: requirement for special stimuli.
    Zupo S; Dono M; Massara R; Taborelli G; Chiorazzi N; Ferrarini M
    Eur J Immunol; 1994 Jun; 24(6):1426-33. PubMed ID: 7515814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
    Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
    Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM.
    Defrance T; Vanbervliet B; Pène J; Banchereau J
    J Immunol; 1988 Sep; 141(6):2000-5. PubMed ID: 2971718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions.
    Rousset F; Billaud M; Blanchard D; Figdor C; Lenoir GM; Spits H; De Vries JE
    J Immunol; 1989 Sep; 143(5):1490-8. PubMed ID: 2547869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
    Engel P; Inglés J; de la Calle O; Gallart T
    Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
    Vandenberghe P; Ceuppens JL
    Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
    Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
    Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).
    Delespesse G; Sarfati M; Peleman R
    J Immunol; 1989 Jan; 142(1):134-8. PubMed ID: 2521231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
    Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
    J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
    Ranheim EA; Kipps TJ
    Cell Immunol; 1995 Apr; 161(2):226-35. PubMed ID: 7535196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory effects of IL-4 on human B-cell response to IL-2.
    Galanaud P; Karray S; Llorente L
    Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of murine B cell Fc gamma RII expression by CD4+ T helper subsets.
    Snapper CM; Hooley JJ; Atasoy U; Finkelman FD; Paul WE
    J Immunol; 1989 Oct; 143(7):2133-41. PubMed ID: 2528589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of surface marker changes and monoclonal idiotypic immunoglobulin secretion in lymphoma/leukemia cells: comparative study with interleukin-1, interleukin-2, interleukin-4, 8-bromo-guanosine, pokeweed mitogen, and tetradecanoyl phorbol-13-acetate.
    Gazitt Y; Gangavalli A; Thurman GB
    Mol Biother; 1989; 1(6):297-304. PubMed ID: 2610949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.